Coronary and carotid atherosclerosis: similarities and differences.

Although a relationship is commonly accepted between coronary and carotid arterial disease, suggesting that atherosclerosis is a systemic condition, the extent of this association and correspondence has not been fully elucidated. This review discusses recent research in this field and highlights areas for future study. The prevalence of severe carotid stenosis increases with prevalence of coronary stenosis, with the latter being found in a significant number of stroke patients, while those with carotid stenosis may be at higher risk of myocardial infarction than stroke. There also appear to be common risk factors (age, diabetes, hypertension, smoking and dyslipidemia), although the effects in both vascular systems may not be identical. Furthermore, while the degree of stenosis in the coronary artery has little ability to predict acute coronary syndrome, which is caused by local thrombosis from a ruptured or eroded plaque, severe carotid stenosis causing hypoperfusion is highly predictive of stroke, although this effect may be time-limited. This apparent difference in event mechanism in the two arteries is interesting as is the difference in the rate of development of collaterals. Overall, the evidence shows that a clear relationship exists between disease in the coronary and carotid arteries, since conventional risk factors and the extent of stenosis and/or previous events emanating from one artery have a strong bearing on the prevalence of events in the other artery. Nevertheless, the exact correspondence between the two arteries is unclear, with sometimes contradictory study results. More research is needed to identify the full extent of risk factors for severe stenosis and cardio- or cerebral vascular events, among which, inflammatory biomarkers such as hs-CRP and prior vascular events are likely to play a key role.

[1]  M. Davies,et al.  Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. , 1996, Circulation.

[2]  R. Nicoll,et al.  Arterial calcification: friend or foe? , 2013, International journal of cardiology.

[3]  L. Symon,et al.  Cerebral arterial pressure changes and development of leptomeningeal collateral circulation , 1963, Neurology.

[4]  M. Levi,et al.  Influenza vaccines for preventing coronary heart disease. , 2008, The Cochrane database of systematic reviews.

[5]  D. O'leary,et al.  Asymptomatic internal carotid artery stenosis defined by ultrasound and the risk of subsequent stroke in the elderly. The Cardiovascular Health Study. , 1998, Stroke.

[6]  FRCP W. J. MacLennan MD,et al.  The Elderly , 1984, Treatment in Clinical Medicine.

[7]  H. Freund,et al.  Cerebral microembolism in symptomatic and asymptomatic high‐grade internal carotid artery stenosis , 1994, Neurology.

[8]  Maarten Schrooten,et al.  Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale , 2009, Stroke.

[9]  P A Schneider,et al.  Noninvasive assessment of CO2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. , 1988, Stroke.

[10]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.

[11]  S. Kashyap,et al.  Correlation of the Extent and Severity of Atherosclerosis in the Coronary and Cerebral Arteries , 1963, Circulation.

[12]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial* , 2011, Stroke.

[13]  Eric E. Smith,et al.  Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target Stroke Initiative , 2011, Stroke.

[14]  塩見 紘樹 Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention : observational study , 2013 .

[15]  G Finet,et al.  Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study , 2002, Circulation.

[16]  M. Naghavi,et al.  Influenza Infection Exerts Prominent Inflammatory and Thrombotic Effects on the Atherosclerotic Plaques of Apolipoprotein E–Deficient Mice , 2003, Circulation.

[17]  Albert van der Zwan,et al.  Anatomy and Functionality of Leptomeningeal Anastomoses: A Review , 2003, Stroke.

[18]  V. Fuster,et al.  Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study , 2009, Circulation. Cardiovascular imaging.

[19]  C. Seiler,et al.  The human coronary collateral circulation , 2003, Heart.

[20]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[21]  S. Nissen Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. , 2005, The American journal of cardiology.

[22]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[23]  R B D'Agostino,et al.  Primary and subsequent coronary risk appraisal: new results from the Framingham study. , 2000, American heart journal.

[24]  A. Norbash,et al.  Cerebral Collateral Circulation in Carotid Artery Disease , 2009, Current cardiology reviews.

[25]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[26]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[27]  W. Schaper,et al.  Collateral Circulation , 1993, Springer US.

[28]  Rowena J Dolor,et al.  Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.

[29]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[30]  D. Liebeskind Collateral circulation. , 2003, Stroke.

[31]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[32]  J. Alpert,et al.  Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Stroke.

[33]  V. Aboyans,et al.  Indications for carotid screening in patients with coronary artery disease. , 2009, Presse medicale.

[34]  L. Solberg,et al.  Distribution of cerebral atherosclerosis by geographic location, race, and sex. , 1968, Laboratory investigation; a journal of technical methods and pathology.

[35]  Y. Kihara,et al.  Determinants of collateral development in patients with acute myocardial infarction , 1999, Clinical cardiology.

[36]  G. Chatellier,et al.  Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis , 2005, Stroke.

[37]  R. J. Valentine,et al.  Trends and outcomes of concurrent carotid revascularization and coronary bypass. , 2008, Journal of vascular surgery.

[38]  P. Sandercock,et al.  Anticoagulants for Acute Ischemic Stroke , 2004, Advances in neurology.

[39]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[40]  P. Shah,et al.  Mechanisms of plaque vulnerability and rupture. , 2003, Journal of the American College of Cardiology.

[41]  R. Califf,et al.  Predictors of left ventricular function after acute myocardial infarction: effects of time to treatment, patency, and body mass index: the GUSTO-I angiographic experience. , 2001, American heart journal.

[42]  G. Moneta,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .

[43]  A. Davies,et al.  Endarterectomy for asymptomatic carotid artery stenosis , 1995, BMJ.

[44]  A. Algra,et al.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.

[45]  J. Ornato,et al.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  Wan Ariffin Bin Abdullah Singapore Med J , 1993 .

[47]  P. Rothwell,et al.  Risk of Coronary and Other Nonstroke Vascular Death in Relation to the Presence and Extent of Atherosclerotic Disease at the Carotid Bifurcation , 2006, Stroke.

[48]  V. Fuster,et al.  Thrombosis in unstable angina. , 1992, The New England journal of medicine.

[49]  Daniel B Hier,et al.  Early Clinical Differentiation of Cerebral Infarction From Severe Atherosclerotic Stenosis and Cardioembolism , 1992, Stroke.

[50]  A. Bol,et al.  Mechanisms of Chronic Regional Postischemic Dysfunction in Humans New Insights From the Study of Noninfarcted Collateral‐Dependent Myocardium , 1993, Circulation.

[51]  D. Weiss,et al.  Cardiac Prognosis of Patients With Carotid Stenosis and No History of Coronary Artery Disease , 1994, Stroke.

[52]  A. Skene,et al.  Survival Outcomes 1 Year After Reperfusion Therapy With Either Alteplase or Reteplase for Acute Myocardial Infarction: Results From the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial , 2000, Circulation.

[53]  E. Vicaut,et al.  Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial , 2011, The Lancet.

[54]  Thomas J. Wang,et al.  The search for new cardiovascular biomarkers , 2008, Nature.

[55]  J. Cutter,et al.  Gender differences in outcome after an acute myocardial infarction in Singapore. , 2002, Singapore medical journal.

[56]  Gary Friday,et al.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American , 2011, Journal of the American College of Cardiology.

[57]  M. Kaste,et al.  Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis , 2003, Neurology.

[58]  Gary Friday,et al.  2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline , 2011, Circulation.

[59]  J. Alpert,et al.  Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Circulation.

[60]  X. Álvarez,et al.  Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events , 2007 .

[61]  Tomohiro Sakamoto,et al.  Echolucent carotid plaques predict future coronary events in patients with coronary artery disease. , 2004, Journal of the American College of Cardiology.

[62]  R. Collins,et al.  C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. , 2011 .

[63]  C. Warlow,et al.  Evidence of a chronic systemic cause of instability of atherosclerotic plaques , 2000, The Lancet.

[64]  Therese Miller,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[65]  L. Solberg,et al.  SEVERITY OF ATHEROSCLEROSIS IN CEREBRAL ARTERIES, CORONARY ARTERIES, AND AORTAS * , 1968, Annals of the New York Academy of Sciences.

[66]  Adrian F Hernandez,et al.  Timeliness of Tissue-Type Plasminogen Activator Therapy in Acute Ischemic Stroke: Patient Characteristics, Hospital Factors, and Outcomes Associated With Door-to-Needle Times Within 60 Minutes , 2011, Circulation.

[67]  D. Calvet,et al.  Coronary Risk Stratification in Patients with Ischemic Stroke or Transient Ischemic Stroke Attack , 2007, International journal of stroke : official journal of the International Stroke Society.

[68]  C F Dewey,et al.  Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  V. Fuster,et al.  Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. , 1985, Journal of the American College of Cardiology.

[70]  Mary Cushman,et al.  Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.

[71]  S L Winters,et al.  Angiographic morphology and the pathogenesis of unstable angina pectoris. , 1985, Journal of the American College of Cardiology.

[72]  Christopher E. Buller,et al.  2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.

[73]  P. Wolf,et al.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: Insights from the framingham study , 2006, Current atherosclerosis reports.

[74]  Peter M. Rothwell,et al.  RISK OF STROKE IN THE DISTRIBUTION OF AN ASYMPTOMATIC CAROTID-ARTERY , 1995 .

[75]  W. Kannel Risk Factors for Atherosclerotic Cardiovascular Outcomes in Different Arterial Territories , 1994, Journal of cardiovascular risk.

[76]  E. Topol,et al.  Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2012, Stroke.

[77]  P. Shan,et al.  Age‐ and gender‐specific prevalence of carotid atherosclerosis and its association with metabolic syndrome in Hangzhou, China , 2012, Clinical endocrinology.

[78]  P. Rothwell,et al.  A systematic review and meta-analysis of 30-day outcomes following staged carotid artery stenting and coronary bypass. , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[79]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[80]  P. Sandercock,et al.  Anticoagulants for acute ischaemic stroke. , 2008, The Cochrane database of systematic reviews.

[81]  George Howard,et al.  Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes , 2008, The Lancet Neurology.

[82]  Heart Protection Study Collaborative Group C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study , 2011, The Lancet.

[83]  Deepak L. Bhatt,et al.  Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry , 2009, European heart journal.

[84]  M. Viergever,et al.  Cerebral hemodynamics in relation to patterns of collateral flow. , 1999, Stroke.

[85]  Raimund Erbel,et al.  [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases]. , 2012, Revue medicale de Liege.

[86]  Jinkwon Kim,et al.  The Frequency and Risk of Preclinical Coronary Artery Disease Detected Using Multichannel Cardiac Computed Tomography in Patients with Ischemic Stroke , 2012, Cerebrovascular Diseases.

[87]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[88]  M. Hennerici,et al.  Coronary Heart Disease Risk in Patients With Stroke or Transient Ischemic Attack and No Known Coronary Heart Disease: Findings From the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2010, Stroke.

[89]  Y. Arbel,et al.  Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. , 2011, Journal of the American College of Cardiology.

[90]  H. Shin,et al.  Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[91]  B. Berk,et al.  Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[92]  A. Grau,et al.  Influenza Vaccination Is Associated With a Reduced Risk of Stroke , 2005, Stroke.

[93]  A. Grau,et al.  Influenza and stroke risk: a key target not to be missed? , 2010, Infectious disorders drug targets.

[94]  W S Moore,et al.  Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. , 1993, The New England journal of medicine.

[95]  G. Simonetti,et al.  Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study. , 2009, JACC. Cardiovascular interventions.

[96]  K. Furie,et al.  Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. , 2008, Stroke.

[97]  R. Corston,et al.  Prognosis in middle cerebral artery stenosis. , 1984, Stroke.

[98]  Scott Hamilton,et al.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.

[99]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .

[100]  D. Lawlor,et al.  Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study , 2000, Journal of epidemiology and community health.